Observations in outsourcing: Survey results show a blended future

Pharmaceutical and biotech organisations are increasing their demand for blended outsourcing solutions to adapt to market challenges, capitalise on innovative opportunities and maintain strategic control. 

ICON commissioned this custom survey to gain a better understanding of how pervasive the desire for blended solutions is across industry sponsors and how biopharmaceutical partners are shifting their outsourcing approaches. Notably, we see increased interest for both FSP and FSO services within an interoperable infrastructure and this interest is likely to increase over the next five years, with 72% of respondents expecting to adopt more flexible outsourcing in that timeframe. 

Read the full survey to gain insight into: 

• Evolving trends in outsourcing models
• Observable benefits of implementing blended models and potential challenges
• Successful outsourcing model implementation and management
• Predictions for the future of outsourcing